Folliculin gene defects are implicated in some forms of infertility, certain cancers and other cell growth disorders.
Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies.
Regenerative therapy for glaucoma is one of the National Eye Institute Audacious Goals.
Stem cell biologists in cancer research are looking into genetically reprogramming B-lymphocytes.
Stem cell biologist Sergei Doulatov is working to improve bone marrow transplant options, understand blood diseases, and maintain healthy blood systems
KNKX Radio follows a group of students from W.F.
Results of a study published today in Nature Biotechnology suggest techniques that could treat patients with heart failure.
Dr. Chuck Murry, director of the UW Institute for Stem Cell and Regenerative Medicine, is among those who worry about some of the promises being made by stem cell clinics.
NPR interviews Charles Murry, a cardiovascular pathologist and director of UW Medicine's Institute for Stem Cell and Regenerative Medicine, about the future of stem cell research.
Researchers built an algorithm to discern which drugs might best combat patients' individual cases of acute myeloid leukemia.